News | July 17, 2023
Evonik and Heraeus cooperate to expand the range of services for highly potent API
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
Approval to dramatically change CAR-T therapies landscape
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
Cipla has a robust governance model focused on sustainability
Subscribe To Our Newsletter & Stay Updated
